How will CVS's stock price change within a month after DOJ lawsuit resolution?
Increase by over 5% • 25%
Increase by 0-5% • 25%
Decrease by 0-5% • 25%
Decrease by over 5% • 25%
Stock price data from financial markets
DOJ Sues CVS for Unlawfully Dispensing Opioids Over a Decade, Alleging Profits Over Safety and Billing Federal Health Insurance Programs
Dec 19, 2024, 02:10 AM
The U.S. Department of Justice (DOJ) has filed a civil lawsuit against CVS Health Corp., accusing the pharmacy chain of unlawfully dispensing controlled substances, including opioids, over a period exceeding a decade. The lawsuit alleges that CVS knowingly filled invalid prescriptions and billed federal health insurance programs for these illegal transactions, contributing to the nationwide opioid crisis. The DOJ's complaint highlights that CVS pharmacies were short-staffed and ignored warnings from pharmacists regarding suspicious prescriptions. The suit was unsealed on December 18, 2024, and claims that CVS prioritized profits over public health and safety, facilitating the unlawful sale of prescription opioids while failing to adhere to the federal Controlled Substances Act.
View original story
Ongoing litigation • 25%
CVS found liable • 25%
Other outcome • 25%
Case dismissed • 25%
CVS settles • 25%
CVS found guilty • 25%
Minor financial penalties • 25%
Severe financial penalties • 25%
Major financial penalties • 25%
No significant impact • 25%
Other • 25%
No significant change • 25%
Decrease by more than 5% • 25%
Increase by more than 5% • 25%
Stock price increases • 25%
Stock price remains stable • 25%
Other outcomes • 25%
Stock price decreases • 25%
CEO resignation • 25%
No change • 25%
Other changes • 25%
Board restructuring • 25%
Decrease by more than 10% • 25%
Decrease by up to 10% • 25%
Increase by up to 10% • 25%
Increase by more than 10% • 25%
Over $5 billion • 25%
No penalty • 25%
Under $1 billion • 25%
$1 billion to $5 billion • 25%
CVS settles • 25%
CVS not liable • 25%
Case dismissed • 25%
CVS found liable • 25%
Other • 25%
No significant change • 25%
Decrease over 10% • 25%
Increase over 10% • 25%
Less than $500 million • 25%
No penalty • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%